Does SIROLIMUS Cause Transplant rejection? 698 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 698 reports of Transplant rejection have been filed in association with SIROLIMUS (sirolimus). This represents 6.1% of all adverse event reports for SIROLIMUS.
698
Reports of Transplant rejection with SIROLIMUS
6.1%
of all SIROLIMUS reports
49
Deaths
117
Hospitalizations
How Dangerous Is Transplant rejection From SIROLIMUS?
Of the 698 reports, 49 (7.0%) resulted in death, 117 (16.8%) required hospitalization, and 139 (19.9%) were considered life-threatening.
Is Transplant rejection Listed in the Official Label?
Yes, Transplant rejection is listed as a known adverse reaction in the official FDA drug label for SIROLIMUS.
What Other Side Effects Does SIROLIMUS Cause?
Off label use (1,960)
Drug ineffective (1,005)
Product use in unapproved indication (984)
Pneumonia (599)
Product use issue (506)
Alopecia (491)
Acne (482)
Transplant dysfunction (468)
Condition aggravated (433)
Ovarian cyst (420)
What Other Drugs Cause Transplant rejection?
TACROLIMUS (3,526)
MYCOPHENOLATE MOFETIL (2,500)
PREDNISONE (1,111)
CYCLOSPORINE (903)
PREDNISOLONE (860)
METHYLPREDNISOLONE (779)
BASILIXIMAB (554)
MYCOPHENOLIC ACID (445)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)
INFLIXIMAB (432)
Which SIROLIMUS Alternatives Have Lower Transplant rejection Risk?
SIROLIMUS vs SIRUKUMAB
SIROLIMUS vs SITAGLIPTIN
SIROLIMUS vs SOAP
SIROLIMUS vs SODIUM
SIROLIMUS vs SODIUM BICARBONATE